Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1999-2-9
|
pubmed:abstractText |
Whether 5- (and the 12- or 15-) lipoxygenases participate in normal or malignantly transformed hematopoietic cell proliferation and differentiation, or contribute to programmed or necrotic cell death has been difficult to decide. Recent evidence concerning these questions is reviewed and some reasons for these difficulties are considered.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0145-2126
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
51-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9933135-Animals,
pubmed-meshheading:9933135-Arachidonate 5-Lipoxygenase,
pubmed-meshheading:9933135-Arachidonate Lipoxygenases,
pubmed-meshheading:9933135-Enzyme Inhibitors,
pubmed-meshheading:9933135-Gene Targeting,
pubmed-meshheading:9933135-Hematopoiesis,
pubmed-meshheading:9933135-Hematopoietic Stem Cells
|
pubmed:year |
1999
|
pubmed:articleTitle |
Do lipoxygenases modulate normal or aberrant lympho-hematopoiesis?
|
pubmed:affiliation |
Department of Medicine, Rush Medical College, Chicago, IL 60612, USA.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|